NEW YORK, March 22 – Fiber optics giant Corning, which has recently secured key partnerships in its effort to mass-produce microarrays, is planning a full-scale commercial launch of its human microarray in June, the company said.

This launch comprises the first major commercialization step in Corning’s microarray marketing plans. “Our intention is to have genome-wide coverage across major organisms of interest,” for the arrays, said John Lubniewski, manager of sales and marketing for Corning Microarray Technologies. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.